SAN FRANCISCO (AP) — SAN FRANCISCO (AP) — FibroGen Inc. (FGEN) on Tuesday reported a loss of $17.1 million in its third quarter.

On a per-share basis, the San Francisco-based company said it had a loss of 17 cents.

The biotech drug developer posted revenue of $46.3 million in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FGEN at https://www.zacks.com/ap/FGEN